
SKINBIOTHERAPEUTICS PLC — Investor Relations & Filings
SkinBioTherapeutics PLC is a life science company focused on advancing skin health by harnessing the human microbiome. Its proprietary SkinBiotix® platform technology utilizes probiotic lysates to protect, manage, and restore skin. The company develops and commercializes products across several healthcare sectors, including cosmetics, food supplements, medical devices, and pharmaceuticals. Key offerings include AxisBiotix, a probiotic food supplement designed to address psoriasis symptoms, and the Dermatonics line of specialized foot care products. Through its acquisition of Bio-Tech Solutions, the company also provides formulation, manufacturing, and packaging services for healthcare, personal care, and hygiene products.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Half-year Results (HY26) and Restated FY25 Results | 2026-06-08 | English | |
| Update on Investigation, Interims and Auditors | 2026-05-28 | English | |
| Holding(s) in Company | 2026-05-12 | English | |
| Holding(s) in Company | 2026-05-05 | English | |
| Update on the FRP Investigation | 2026-04-29 | English | |
| Holding(s) in Company | 2026-04-01 | English |
Browse filings by year
11 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 47993242 | Half-year Results (HY26) and Restated FY25 Results | 2026-06-08 | English | ||
| 47854181 | Update on Investigation, Interims and Auditors | 2026-05-28 | English | ||
| 45196883 | Holding(s) in Company | 2026-05-12 | English | ||
| 41399911 | Holding(s) in Company | 2026-05-05 | English | ||
| 38609930 | Update on the FRP Investigation | 2026-04-29 | English | ||
| 33558645 | Holding(s) in Company | 2026-04-01 | English | ||
| 33128178 | Statement re. Suspension | 2026-04-01 | English | ||
| 32998789 | Update On Board Investigation and Interims Date | 2026-03-20 | English | ||
| 32940296 | Holding(s) in Company | 2026-03-13 | English | ||
| 32916168 | Appointment of the Interim CEO to the Board | 2026-03-09 | English | ||
| 32859740 | Appointment of Interim CEO | 2026-03-02 | English | ||
| 32600703 | Independent Investigation Appointment | 2026-02-20 | English | ||
| 34561022 | Update on Board Investigation | 2026-02-16 | English | ||
| 34560003 | Resignation of CEO | 2026-02-13 | English | ||
| 34559291 | Holding(s) in Company | 2026-02-12 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for SKINBIOTHERAPEUTICS PLC, but not for this combination of statement and period. Try a different combination.
Swipe the table to view all periods, or rotate your phone for a wider view.
| Line item | ! |
|---|---|
| Definition not yet available — coming soon. |
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Abbott Laboratories (Pakistan) Limited
Manufactures and markets diverse healthcare products: pharm…
|
ABOT | PK | Manufacturing |
|
AbbVie Inc.
A research-based biopharmaceutical company developing and m…
|
ABBV | US | Manufacturing |
|
AbCellera Biologics Inc.
Discovers and develops antibody-based therapeutics using a …
|
ABCL | CA | Manufacturing |
|
AbClon Inc.
Develops antibody-based therapeutics using CAR-T, NEST, and…
|
174900 | KR | Manufacturing |
|
ABEONA THERAPEUTICS INC.
A clinical-stage biopharma developing cell and gene therapi…
|
ABEO | US | Manufacturing |
|
ABINGDON HEALTH PLC
A CDMO specializing in lateral flow assays, offering develo…
|
ABDX | GB | Manufacturing |
|
ABIONYX Pharma
Develops biotherapies and drug delivery vectors using apoli…
|
ABNX | FR | Manufacturing |
|
ABIVAX
Clinical-stage biotech developing therapeutics for chronic …
|
ABVX | FR | Manufacturing |
|
Abivax S.A.
Clinical-stage biotech developing miRNA therapeutics for in…
|
ABVX | US | Manufacturing |
|
ABL Diagnostics
Develops molecular diagnostic solutions for managing infect…
|
ABLD | FR | Manufacturing |
SKINBIOTHERAPEUTICS PLC via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/7920/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=7920 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=7920 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=7920 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 7920}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for SKINBIOTHERAPEUTICS PLC (id: 7920)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.